Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis

被引：6

作者：

Nicolai, R. ^{[1
]}

Cortis, E. ^{[4
]}

Rava, L. ^{[3
]}

Bracaglia, C. ^{[1
]}

Pardeo, M. ^{[1
]}

Insalaco, A. ^{[1
]}

Buonuomo, P. S. ^{[2
]}

Tozzi, A. E. ^{[3
]}

De Benedetti, F. ^{[1
]}

机构：

[1] Bambino Gesu Pediat Hosp, Dept Pediat Med, IRCCS, Div Rheumatol, Piazza St Onofrio 4, I-00165 Rome, Italy

[2] Bambino Gesu Pediat Hosp, Dept Pediat Med, Ist Ricovero & Cura Carattere Sci, Div Rare Dis, Rome, Italy

[3] Bambino Gesu Pediat Hosp, Div Epidemiol, Ist Ricovero & Cura Carattere Sci, Rome, Italy

[4] Osped Santa Maria Stella, Div Pediat, Orvieto, Italy

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2016年 / 5卷 / 01期

关键词：

etanercept; herpes simplex virus; juvenile idiopathic arthritis; varicella zoster virus; RHEUMATOID-ARTHRITIS; SAFETY; EFFICACY; REGISTRY; CHILDREN; THERAPY;

D O I：

10.1093/jpids/piu078

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Incidence rates for varicella and herpes zoster were similar in patients with juvenile idiopathic arthritis receiving etanercept/methotrexate (n = 85, 184.9 patient-years [PY]) or methotrexate alone (n = 71, 199.4 PY); no complicated varicella or herpes zoster cases were reported; herpes labialis incidence was higher in patients receiving etanercept/methotrexate versus methotrexate alone (0.38 vs 0.24 PY).

引用

页码：76 / 79

页数：4

共 50 条

[31] Response to Etanercept in Juvenile Idiopathic Arthritis Reply
Otten, Marieke H.
Prince, Femke H. M.
van Suijlekom-Smit, Lisette W. A.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (11): : 1140 - 1141
[32] ETANERCEPT CONCENTRATION IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
Karki, J.
Levalampi, T.
Vahasalo, P.
Backstrom, M.
Kroger, L.
Malin, M.
Putto-Laurila, A.
Pohjankoski, H.
Kautiainen, H.
Jokiranta, S.
Aalto, K.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1196 - 1197
[33] Etanercept and uveitis in patients with juvenile idiopathic arthritis
Schmeling, H
Horneff, G
RHEUMATOLOGY, 2005, 44 (08) : 1008 - 1011
[34] ETANERCEPT RESPONSE CLUSTERS IN JUVENILE IDIOPATHIC ARTHRITIS
Shoop-Worrall, S.
Hyrich, K.
Wedderburn, L.
Thomson, W.
Geifman, N.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 97 - 98
[35] PREDICTORS OF RESPONSE TO ETANERCEPT TREATMENT DEPENDING ON JUVENILE IDIOPATHIC ARTHRITIS CATEGORY
Kashchenko, E.
Alexeeva, E.
Bzarova, T.
Valieva, S.
Denisova, R.
Lomakina, O.
Isaeva, K.
Soloshenko, M.
Karaseva, A.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1387 - 1387
[36] Discontinuation of Etanercept After Successful Treatment in Patients with Juvenile Idiopathic Arthritis
Remesal, Agustin
De Inocencio, Jaime
Merino, Rosa
Garcia-Consuegra, Julia
JOURNAL OF RHEUMATOLOGY, 2010, 37 (09) : 1970 - 1971
[37] Etanercept in juvenile idiopathic arthritis: Who will benefit?
MH Otten
FHM Prince
W Armbrust
R ten Cate
EPAH Hoppenreijs
M Twilt
Y Koopman-Keemink
SL Gorter
KM Dolman
JF Swart
JM van den Berg
NM Wulffraat
MAJ van Rossum
LWA van Suijlekom-Smit
Pediatric Rheumatology, 9 (Suppl 1)
[38] Etanercept and uveitis in patients with juvenile idiopathic arthritis
Schmeling, H
Winkler, A
Horneff, G
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 384 - 384
[39] Etanercept and urticaria in patients with juvenile idiopathic arthritis
Skyttä, E
Pohjankoski, H
Savolainen, A
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (04) : 533 - +
[40] Challenges in the management of juvenile idiopathic arthritis with etanercept
Pain, Clare E.
McCann, Liza J.
BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 127 - 139

← 1 2 3 4 5 →